Eve Merry

591 total citations
10 papers, 282 citations indexed

About

Eve Merry is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Eve Merry has authored 10 papers receiving a total of 282 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Pulmonary and Respiratory Medicine and 4 papers in Epidemiology. Recurrent topics in Eve Merry's work include COVID-19 and healthcare impacts (3 papers), Congenital Heart Disease Studies (2 papers) and Vascular Tumors and Angiosarcomas (1 paper). Eve Merry is often cited by papers focused on COVID-19 and healthcare impacts (3 papers), Congenital Heart Disease Studies (2 papers) and Vascular Tumors and Angiosarcomas (1 paper). Eve Merry collaborates with scholars based in United Kingdom and United States. Eve Merry's co-authors include Michael R. Ehrenstein, Konstantia-Maria Chavele, Robin L. Jones, Khin Thway, Shane Zaidi, Alannah Smrke, Spyridon Gennatas, Paul H. Huang, Roger Wilson and Charlotte Benson and has published in prestigious journals such as The Journal of Immunology, Cancers and International Journal of Gynecological Cancer.

In The Last Decade

Eve Merry

9 papers receiving 280 citations

Peers

Eve Merry

ONCOL

PHEOH

IMMUN

PRM

GHP

Elizabeth F. Krakow United States

Sharon Avery Australia

S J Lee United States

Cécile Fortanier France

Eoin McGrath Netherlands

Ghada Elgohary Egypt

Ila M. Saunders United States

Elizabeth Stenger United States

Lyndsey Runaas United States

Pamela Spain United States

Elizabeth F. Krakow United States

Eve Merry

81 ×0.6

ONCOL

71 ×0.8

PHEOH

47 ×0.7

IMMUN

17 ×0.4

PRM

22 ×0.6

GHP

Citations per year, relative to Eve Merry Eve Merry (= 1×) peers Elizabeth F. Krakow

Countries citing papers authored by Eve Merry

Since Specialization

Citations

This map shows the geographic impact of Eve Merry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eve Merry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eve Merry more than expected).

Fields of papers citing papers by Eve Merry

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eve Merry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eve Merry. The network helps show where Eve Merry may publish in the future.

Co-authorship network of co-authors of Eve Merry

This figure shows the co-authorship network connecting the top 25 collaborators of Eve Merry. A scholar is included among the top collaborators of Eve Merry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eve Merry. Eve Merry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Merry, Eve & Charlie Gourley. (2025). Targeting DNA Damage Repair Pathways Beyond PARP Inhibition. Targeted Oncology. 20(6). 937–953.

2.

Merry, Eve, Michael Flynn, Jonathan A. Ledermann, et al.. (2024). A multicenter retrospective study to assess feasibility, safety and efficacy of first-line carboplatin-paclitaxel versus carboplatin monotherapy in a frail, elderly epithelial ovarian cancer population☆. International Journal of Gynecological Cancer. 35(9). 101853–101853. 1 indexed citations

3.

Merry, Eve, Khin Thway, Robin L. Jones, & Paul H. Huang. (2021). Predictive and prognostic transcriptomic biomarkers in soft tissue sarcomas. npj Precision Oncology. 5(1). 17–17. 37 indexed citations

4.

Wong, Yien Ning Sophia, Christopher C.T. Sng, Diego Ottaviani, et al.. (2021). Systemic Anti-Cancer Therapy and Metastatic Cancer Are Independent Mortality Risk Factors during Two UK Waves of the COVID-19 Pandemic at University College London Hospital. Cancers. 13(23). 6085–6085. 2 indexed citations

5.

Merry, Eve, et al.. (2020). Paraneoplastic dermatomyositis associated with metastatic leiomyosarcoma of unknown primary. PubMed. 10(1). 15–15. 2 indexed citations

6.

Younger, Eugenie, Alannah Smrke, Emma Lidington, et al.. (2020). Health-Related Quality of Life and Experiences of Sarcoma Patients during the COVID-19 Pandemic. Cancers. 12(8). 2288–2288. 46 indexed citations

7.

Smrke, Alannah, Eugenie Younger, Roger Wilson, et al.. (2020). Telemedicine During the COVID-19 Pandemic: Impact on Care for Rare Cancers. JCO Global Oncology. 6(6). 1046–1051. 89 indexed citations

8.

Chavele, Konstantia-Maria, Eve Merry, & Michael R. Ehrenstein. (2015). Cutting Edge: Circulating Plasmablasts Induce the Differentiation of Human T Follicular Helper Cells via IL-6 Production. The Journal of Immunology. 194(6). 2482–2485. 103 indexed citations

9.

Godt, Robert E., et al.. (1997). Depressed ventricular contractility in an experimental heart defect in the embryonic chick is not associated with an elevated microtubule content. 373–383. 1 indexed citations

10.

Lutin, William A., C. Jones, Eve Merry, C.E. Nichols, & M. L. Montgomery. (1996). Abnormalities in ventricular function in human fetuses with congenital heart disease. 44(1). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact